The E8 domain confers a novel long-distance transcriptional repression activity on the E8̂E2C protein of high-risk human papillomavirus type 31

Journal of Virology

Volumn 75, Issue 9, 2001, Pages 4139-4149

  Stubenrauch, F ^a   Zobel, T ^a   Iftner, T ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CELL IMMORTALIZATION; CIS TRANS ISOMERISM; CONTROLLED STUDY; DNA REPLICATION; GENE EXPRESSION; GENITAL TRACT CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; TRANSCRIPTION REGULATION; VIRUS REPLICATION; WART VIRUS;

CONSERVED SEQUENCE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMANS; LYSINE; PAPILLOMAVIRIDAE; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRYPTOPHAN; VIRAL PROTEINS;

EID: 0035043328     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.9.4139-4149.2001     Document Type: Article

References (58)

1. Mechanism of action of the papillomavirus E2 repressor: Repression in the absence of DNA binding
2. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes
3. Characterization of the human papillomavirus E2 protein: Evidence of trans-activation and trans-repression in cervical keratinocytes
4. An E1M̂E2C fusion protein encoded by human papillomavirus type 11 is a sequence-specific transcription repressor
5. Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins
6. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: Functional and biochemical studies
7. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: Structural and functional analysis of new viral cDNAs
8. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes
9. The E2 transcriptional repressor can compensate for SP1 activation of the human papillomavirus type 18 early promoter
10. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis
11. Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes
12. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements
13. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line
14. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex
15. Suppression of cellular proliferation by the papillomavirus E2 protein
16. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells
17. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates
18. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression
19. Several different upstream promoter elements can potentiate transactivation by the BPV-1 E2 protein
20. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions
21. Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex
22. Papillomavirinae: The viruses and their replication
23. Bovine papilloma virus-transformed cells contain multiple E2 proteins
24. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes
25. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene
26. Sin meets NuRD and other tails of repression
27. Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells
28. A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator
29. Competition for DNA binding sites between the short and long forms of E2 dimers underlies repression in bovine papillomavirus type 1 DNA replication control
30. The functions of human papillomavirus type 11 E1, E2, and E2C proteins in cell-free DNA replication
31. Repression: Targeting the heart of the matter
32. The papillomavirus E2 regulatory proteins
33. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: Transactivation is mediated by the conserved amino-terminal domain
34. Immortalization and transformation of human cells by human papillomavirus
35. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA
36. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b
37. Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation
38. Malignant transformation of cutaneous lesions in renal allograft patients: A role for human papillomavirus
39. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2
40. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas
41. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity
42. 105 promoters
43. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction
44. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10
45. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms
46. Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites
47. The bovine papillomavirus 1 E2 protein contains two activation domains: One that interacts with TBP and another that functions after TBP binding
48. Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions
49. The E8̂E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes
50. Human papillomavirus life cycle: Active and latent phases
51. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors
52. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31
53. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element
54. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID
55. Functional analysis of E2-mediated repression of the HPV18 P105 promoter
56. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region
57. Papillomavirus infections - A major cause of human cancers
58. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types